Psychopathology in patients with psoriasis: a cross-sectional clinical study

Background: Psoriasis is associated with a variety of psychological problems including poor self-esteem, sexual dysfunction, anxiety and depressive disorder and suicidal ideation. There are reports that patients with psoriasis may have significant psychiatric morbidity. The objective of the study is to evaluate the frequency of psychiatric disorders, frequency and nature of psychiatric symptoms in patients with psoriasis.Methods: 100 patients with psoriasis were evaluated and included for the study. Comprehensive Psychopathological Rating Scale (CPRS) is used for assessment of psychiatric symptoms and MINI Plus for assessing psychiatric disorders. Chi-square test was used to compare the proportions.Results: Patients with psoriasis had high frequency of psychiatric morbidity and was found to be 42%.Conclusions: Patients with psoriasis have more psychopathology and higher psychiatric morbidity which may further imply justifiable consultation liaison psychiatry in other speciality fields like Dermatology.

Dermatite factícia: relato de um caso exuberante / Factitial dermatitis: report of an exuberant case

Dermatite factícia é uma condição na qual o paciente provoca lesões na própria pele, negando qualquer envolvimento no surgimento das mesmas. O aspecto da lesão é variável, com morfologia relacionada com o objeto utilizado. Representam com frequência um desafio diagnóstico devido à dificuldade de obtenção de informações verídicas na anamnese. Relata-se caso clínico com apresentação exuberante em paciente feminina de 45 anos, enfatizando a importância da abordagem multiprofissional nas dermatoses psicogênicas.

Unusual Findings in Morgellons Disease and Delusions of Parasitosis.

We are presenting four new cases of delusions of parasitosis, two of which also had features of Morgellons disease. This illustrates the difficulties in therapy of these patients having almost universal refusal to accept the psychiatric component. Two of the patients responded to treatment while two did not. Of the two responders one was lost to follow up. The recommended treatments of pimozide, lexapro, and risperdone are examined. These rare diseases continue to be a challenge to the dermatologic community.